161 related articles for article (PubMed ID: 12701832)
1. Effect of directly observed preventive therapy for latent tuberculosis infection in San Francisco.
White MC; Gournis E; Kawamura M; Menendez E; Tulsky JP
Int J Tuberc Lung Dis; 2003 Jan; 7(1):30-5. PubMed ID: 12701832
[TBL] [Abstract][Full Text] [Related]
2. Directly observed therapy (DOT) is not the entire answer: an operational cohort analysis.
Mangura B; Napolitano E; Passannante M; Sarrel M; McDonald R; Galanowsky K; Reichman L
Int J Tuberc Lung Dis; 2002 Aug; 6(8):654-61. PubMed ID: 12150475
[TBL] [Abstract][Full Text] [Related]
3. Incidence of TB in inmates with latent TB infection: 5-year follow-up.
White MC; Tulsky JP; Menendez E; Goldenson J; Kawamura LM
Am J Prev Med; 2005 Nov; 29(4):295-301. PubMed ID: 16242592
[TBL] [Abstract][Full Text] [Related]
4. Acceptance and safety of directly observed versus self-administered isoniazid preventive therapy in aboriginal peoples in British Columbia.
Heal G; Elwood RK; FitzGerald JM
Int J Tuberc Lung Dis; 1998 Dec; 2(12):979-83. PubMed ID: 9869112
[TBL] [Abstract][Full Text] [Related]
5. Use of intermittent rifampin and pyrazinamide therapy for latent tuberculosis infection in a targeted tuberculin testing program.
Priest DH; Vossel LF; Sherfy EA; Hoy DP; Haley CA
Clin Infect Dis; 2004 Dec; 39(12):1764-71. PubMed ID: 15578397
[TBL] [Abstract][Full Text] [Related]
6. Directly observed treatment for tuberculosis in pharmacies compared with self-administered therapy in Spain.
Juan G; Lloret T; Perez C; Lopez P; Navarro R; Ramón M; Cortijo J; Morcillo EJ
Int J Tuberc Lung Dis; 2006 Feb; 10(2):215-21. PubMed ID: 16499264
[TBL] [Abstract][Full Text] [Related]
7. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City.
Li J; Munsiff SS; Tarantino T; Dorsinville M
Int J Infect Dis; 2010 Apr; 14(4):e292-7. PubMed ID: 19656705
[TBL] [Abstract][Full Text] [Related]
8. Twice-weekly therapy for children with tuberculosis infection or exposure.
Cruz AT; Starke JR
Int J Tuberc Lung Dis; 2013 Feb; 17(2):169-74. PubMed ID: 23317951
[TBL] [Abstract][Full Text] [Related]
9. [Accessibility and compliance of Ethiopian immigrants to latent tuberculosis infection treatment].
Bishara H; Ore L; Bshara H; Vinitsky O; Armaly N; Weiler-Ravell D
Harefuah; 2014 Jan; 153(1):8-11, 66. PubMed ID: 24605398
[TBL] [Abstract][Full Text] [Related]
10. Results of directly observed treatment for tuberculosis in Ensenada, Mexico: not all DOTS programs are created equally.
Radilla-Chávez P; Laniado-Laborín R
Int J Tuberc Lung Dis; 2007 Mar; 11(3):289-92. PubMed ID: 17352094
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis among drug users at high risk for tuberculosis.
Gourevitch MN; Alcabes P; Wasserman WC; Arno PS
Int J Tuberc Lung Dis; 1998 Jul; 2(7):531-40. PubMed ID: 9661818
[TBL] [Abstract][Full Text] [Related]
12. In closely monitored patients, adherence in the first month predicts completion of therapy for latent tuberculosis infection.
Menzies D; Dion MJ; Francis D; Parisien I; Rocher I; Mannix S; Schwartzman K
Int J Tuberc Lung Dis; 2005 Dec; 9(12):1343-8. PubMed ID: 16466056
[TBL] [Abstract][Full Text] [Related]
13. Improvements in treatment success rates with directly observed therapy in Rio de Janeiro City.
Soares EC; Pacheco AG; Mello FC; Durovni B; Chaisson RE; Cavalcante SC
Int J Tuberc Lung Dis; 2006 Jun; 10(6):690-5. PubMed ID: 16776458
[TBL] [Abstract][Full Text] [Related]
14. Experiences of a community-based tuberculosis treatment programme in Namibia: a comparative cohort study.
Zvavamwe Z; Ehlers VJ
Int J Nurs Stud; 2009 Mar; 46(3):302-9. PubMed ID: 18995854
[TBL] [Abstract][Full Text] [Related]
15. Community DOT for tuberculosis in a Brazilian favela: comparison with a clinic model.
Cavalcante SC; Soares EC; Pacheco AG; Chaisson RE; Durovni B;
Int J Tuberc Lung Dis; 2007 May; 11(5):544-9. PubMed ID: 17439679
[TBL] [Abstract][Full Text] [Related]
16. Directly observed treatment is associated with reduced default among foreign tuberculosis patients in Thailand.
Kapella BK; Anuwatnonthakate A; Komsakorn S; Moolphate S; Charusuntonsri P; Limsomboon P; Wattanaamornkiat W; Nateniyom S; Varma JK
Int J Tuberc Lung Dis; 2009 Feb; 13(2):232-7. PubMed ID: 19146753
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis treatment outcome monitoring: Blackburn 1988-2000.
Ormerod LP; Horsfield N; Green RM
Int J Tuberc Lung Dis; 2002 Aug; 6(8):662-5. PubMed ID: 12150476
[TBL] [Abstract][Full Text] [Related]
19. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
Elzi L; Schlegel M; Weber R; Hirschel B; Cavassini M; Schmid P; Bernasconi E; Rickenbach M; Furrer H;
Clin Infect Dis; 2007 Jan; 44(1):94-102. PubMed ID: 17143823
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy.
Jasmer RM; Seaman CB; Gonzalez LC; Kawamura LM; Osmond DH; Daley CL
Am J Respir Crit Care Med; 2004 Sep; 170(5):561-6. PubMed ID: 15184210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
